Document 0657 DOCN M9650657 TI Cytomegalovirus keratitis after penetrating keratoplasty. DT 9605 AU Wehrly SR; Manning FJ; Proia AD; Burchette JL; Foulks GN; Department of Ophthalmology, Duke University Medical Center,; Durham, North Carolina 27710, USA. SO Cornea. 1995 Nov;14(6):628-33. Unique Identifier : AIDSLINE MED/96155585 AB We report the development of cytomegalovirus (CMV) keratitis in the penetrating keratoplasty of a 59-year-old human immunodeficiency virus-negative woman after uncomplicated corneal transplantation. Immunosuppression with topical cyclosporine A 2% in corn oil and topical prednisolone acetate 1% suspension was used postoperatively. The 15-month postoperative course was complicated by multiple episodes of endothelial rejection, medically controlled elevated intraocular pressure, polymicrobial bacterial (coagulase-negative staphlococcus and alpha-hemolytic streptococcus) keratitis, and endothelial plaque formation with associated hypopyon and epithelial defect. The graft failed and penetrating keratoplasty was repeated. Cytomegalovirus infection of superficial keratocytes in a region of scarring was identified in histological sections stained with hematoxylin and eosin and confirmed using mouse monoclonal anti-cytomegalovirus antibodies. Excision of the diseased corneal button with no additional treatment appears to have been curative. Low-grade keratitis was the only manifestation of the CMV infection, and it has not recurred 6 months postoperatively. DE Anti-Inflammatory Agents, Steroidal/ADMINISTRATION & DOSAGE Antibodies, Monoclonal Antigens, Viral/ANALYSIS Case Report Cornea/PATHOLOGY/SURGERY/VIROLOGY Corneal Stroma/PATHOLOGY/VIROLOGY Cyclosporine/ADMINISTRATION & DOSAGE Cytomegalovirus/IMMUNOLOGY Cytomegalovirus Infections/*ETIOLOGY/PATHOLOGY Eye Infections, Viral/*ETIOLOGY/PATHOLOGY Female Graft Rejection/DRUG THERAPY/ETIOLOGY Human Immunoenzyme Techniques Immunosuppressive Agents/ADMINISTRATION & DOSAGE Keratitis/PATHOLOGY/*VIROLOGY Keratoplasty, Penetrating/*ADVERSE EFFECTS Middle Age Ophthalmic Solutions Prednisolone/ADMINISTRATION & DOSAGE Reoperation JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).